Amgen - Media - Immunex Press Release Archives About Amgen Science Corporate Philanthropy Site Map Search Privacy & Terms Contact Us Patients Medical Professionals Partners Investors Careers Media print Home Media Immunex Press Release Archives Overview Fact Sheets Featured Content Press Releases Tularik Press Release Archives Immunex Press Release Archives Awards & Recognition Media Contacts Immunex Press Releases 2002 Immunex...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, GANTANOL to LYSODREN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS GANTANOL to LYSODREN Trade Name Generic GANTANOL Sulfamethoxazole GANTRISIN Sulfisoxazole GARAMYCIN Gentamicin GEOCILLIN Carbenicillin GLUCOPHAGE Metformin GLUCOTROL Glipizide GRIFULVIN V Griseofulvin GRISACTIN Griseofulvin HALCION Triazolam HALDOL Haloperidol HALDRONE Paramethasone HALOTESTIN...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs. Salmeterol to Zolpidem Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Salmeterol to Zolpidem Generic Trade Name Salmeterol SEREVENT Salsalate DISALCID, SALFLEX Saquinavir FORTOVASE Sargramostim LEUKINE Secobarbital SECONAL Selegiline ELDEPRYL Selenium SELSUN Sertraline ZOLOFT Sibutramine MERIDIA Sildenafil VIAGRA Silver sulfadiazine SILVADENE Simethicone...
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr Amgen completed its acquisition of Immunex Corporation on July 15, 2002.
author: pmannle
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr Amgen completed its acquisition of Immunex Corporation on July 15, 2002.
author: pmannle
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr page 1
author: pmannle
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr Amgen completed its acquisition of Immunex Corporation on July 15, 2002.sargramostim) totaled a record $108.4 million for the year 2001, up 23...
author: pmannle
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr page 2
author: pmannle
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr Amgen completed its acquisition of Immunex Corporation on July 15, 2002.sargramostim) to Schering AG Germany SEATTLE, WA, USA and BERLIN, GERMANY Immunex Corporation (Nasdaq: IMNX) today announced that it has entered into a definitive agreement to sell its LEUKINE® (sargramostim) business to...
author: pmannle
file://C:\Documents%20and%20Settings\pmannle\Desktop\Immunex\pr page 1
author: pmannle
Hematopoietic stimulants - [Medication] - Quest Diagnostics Patient Health Library Hematopoietic stimulants Examples Brand Name Chemical Name Neupogen, G-CSF filgrastim Leukine, Prokine, GM-CSF sargramostim Hematopoietic stimulants are injected under the skin (subcutaneously, or SQ).
Btech News - AMGEN'S NEULASTA APPROVED - - - - BioNews BioWeb Companies Products BioReports - - - - - - Btech News - AMGEN'S NEULASTA APPROVED Late yesterday afternoon, the FDA approved Neulasta for marketing in the U.S.
BioPortfolio Limited Colony Stimulating Factors Current Market Dynamics & Future Outlook 1.Leukine (Sargramostim) ...
New Topics Obstetrics Case Management for High-Risk Pregnancy Enoxiparin (Lovenox) and its Safety in Pregnancy External Cephalic Version for the Management of Breech Presentation Fibrin Sealant for Treatment of Preterm Premature Rupture of Membrane (PROM) In Utero Surgical Treatment for Congenital Cystic Adenomatoid Malformation In Utero Surgical Treatment for Fetal Diaphragmatic Hernia In...
CBER - Index J-M FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page CBER Index A to C | D to F | G to I | J to M | N to P | Q to S | T to Z Koate-DVI (Antihemophilic Factor (Human)) Kogenate FS, Helixate FS (Antihemophilic Factor (Recombinant)) Labeling for Biological Products Laws Letters Letters to Industry / Healthcare Providers Notice of Initiation of Disqualification...
author: CBER / FDA
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, GANTANOL to LYSODREN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS GANTANOL to LYSODREN Trade Name Generic GANTANOL Sulfamethoxazole GANTRISIN Sulfisoxazole GARAMYCIN Gentamicin GEOCILLIN Carbenicillin GLUCOPHAGE Metformin GLUCOTROL Glipizide GRIFULVIN V Griseofulvin GRISACTIN Griseofulvin HALCION Triazolam HALDOL Haloperidol HALDRONE Paramethasone HALOTESTIN...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs. Salmeterol to Zolpidem Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Salmeterol to Zolpidem Generic Trade Name Salmeterol SEREVENT Salsalate DISALCID, SALFLEX Saquinavir FORTOVASE Sargramostim LEUKINE Secobarbital SECONAL Selegiline ELDEPRYL Selenium SELSUN Sertraline ZOLOFT Sibutramine MERIDIA Sildenafil VIAGRA Silver sulfadiazine SILVADENE Simethicone...
Pharmaceutical Research and Manufacturers of America - Berlex Laboratories Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes azelaic acid none / none rosacea Berlex Laboratories Montville, NJ application submitted - Climara Pro none / none Osteoporosis Berlex...
Pharmaceutical Research and Manufacturers of America - Colon Cancer Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes 8C1.cAMP none / 8C1.cAMP Colon Cancer ICN Pharmaceuticals Costa Mesa, CA Phase I - AG-002037 none / none Breast Cancer Colon Cancer Lung Cancer...
Berlex Laboratories, Inc. announces initiation of Leukine® Phase III study for Crohn's disease -We are optimistic about the initial review of the data from the most-recent Leukine Crohn's disease trial,- said Reinhard Franzen, president and chief executive officer, Berlex Laboratories, IncLeukine experienced a significant decrease in disease symptoms over...
Berlex Laboratories Announces Results From Randomized, Placebo-Controlled Study Of Leukine(R) For Crohn's Disease To verify the positive pilot trial results, investigators from Washington University, as well as investigators at 34 additional trial sites across the United States, evaluated 124 patients in the Phase II trial to study the efficacy and safety of LEUKINE, which stimulates the immune system, in the treatment of moderately to severely active Crohn's disease
http://www.easy.no/affitech/pdf/das1.pdf page 1
duplicates:http://www.iscpubs.com/articles/abl/b0002das.pdf
Prescription Drug User Fee Act - User Fee Billable Therapeutic Products: Approved Under Section 351 of the PHS Act Tradename(s) / Proper Name BLA STN BLA Approval Date Billable Potencies Abbott Laboratories License 0043 Humira Adalimumab 125057/0 12/31/2002 40 mg/0.8mL Advance Biofactures Corp License 0383 Santyl Collagenase 101995/0 6/4/1965 - Allergan, Inc License 1145 Botox Botox Cosmetic Botulinum Toxin Type A 103000/0 12/9/1991 100 u/vial Amgen, Inc License 1080 Kineret Anakinra 103950/0 11...
CMC Review - Etanercept, Enbrel - Immunex, Corp. page 4
author: CBER
The "Immunex All Stars" Celebrate 20 Years of Breakthrough Science - Amgen completed its acquisition of Immunex Corporation on July 15, 2002
